CoChat

A novel cognitive disease progression model for clinical trials in autosomal‐dominant Alzheimer's disease

Open access
Wang, Guoqiao, Berry, Scott, Xiong, Chengjie, Hassenstab, Jason, Quintana, Melanie, McDade, Eric M., Delmar, Paul, Vestrucci, Matteo, Sethuraman, Gopalan, Bateman, Randall J., For the Dominantly Inherited Alzheimer Network Trials Unit · 2018 · Statistics in Medicine
Cited by 58

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Clinical trial outcomes for Alzheimer's disease are typically analyzed by using the mixed model for repeated measures (MMRM) or similar models that compare an efficacy scale change from baseline between treatment arms with or without participants' disease stage as a covariate. The MMRM focuses on a single‐point fixed follow‐up duration regardless of the exposure for each participant. In contrast to these typical models, we have developed a novel semiparametric cognitive disease progression model (DPM) for autosomal dominant Alzheimer's disease based on the Dominantly Inherited Alzheimer Network (DIAN) observational study. This model includes 3 novel features, in which the DPM (1) aligns and compares participants by disease stage, (2) uses a proportional treatment effect similar to the concept of the Cox proportional hazard ratio, and (3) incorporates extended follow‐up data from participants with different follow‐up durations using all data until last participant visit. We present the DPM model developed by using the DIAN observational study data and demonstrate through simulation that the cognitive DPM used in hypothetical intervention clinical trials produces substantial gains in power compared with the MMRM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/sim.7811

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 58

Metadata

Authors
Wang, G., Berry, S., Xiong, C., Hassenstab, J., Quintana, M., McDade, E. M., Delmar, P., Vestrucci, M., Sethuraman, G., Bateman, R. J., & For the Dominantly Inherited Alzheimer Network Trials Unit
Venue
Statistics in Medicine
Publisher
Wiley
Published
2018-05-14
Volume
37
Issue
21
Pages
3047-3055
ISSN
  • 0277-6715 (ISSN-L)
  • 1097-0258
OpenAlex
W2804711484
Cited by
58
References
13
FWCI
2.62
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A novel cognitive disease progression model for clinical trials in autosomal‐dominant Alzheimer's disease. https://app.cochat.ai/papers/10.1002/sim.7811
The paper
Wang, G., Berry, S., Xiong, C., Hassenstab, J., Quintana, M., McDade, E. M., Delmar, P., Vestrucci, M., Sethuraman, G., Bateman, R. J., & For the Dominantly Inherited Alzheimer Network Trials Unit. (2018). A novel cognitive disease progression model for clinical trials in autosomal‐dominant Alzheimer's disease. Statistics in Medicine. https://doi.org/10.1002/sim.7811

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.